Trials Sponsors Conditions Drugs Pricing

Conditions

Covid19 Periodontitis

Keywords

COVID-19Human microbiomeOral microbiomeSARS-CoV-2 infection

Outcome Measures

Primary Outcomes (1)

Oral microbial signature
To assess the oral microbial signatures that relates to SARS-CoV2 in patients with no, mild and severe disease.
Day 1

Secondary Outcomes (1)

Nasal microbial signature
Day 1

Study Arms (3)

Controls tested PCR (-) for COVID-19

Other: Swab

Tested PCR (+) for COVID-19, Mild - not admitted to the hospital

Other: Swab

Tested PCR (+) for COVID-19, Severe - admitted to ICU (Intensive Care Unit)

Other: Swab

Interventions

SwabOther

PCR test for SARS-CoV2, oral and nasal swab

Controls tested PCR (-) for COVID-19Tested PCR (+) for COVID-19, Mild - not admitted to the hospitalTested PCR (+) for COVID-19, Severe - admitted to ICU (Intensive Care Unit)

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age18 Years+

Sexall

Healthy VolunteersYes

Age GroupsAdult (18-64), Older Adult (65+)

Sampling MethodNon-Probability Sample

Study Population

Adults who tested (PCR) positive or negative for SARS-CoV2 infection

You may qualify if:

Must provide written informed consent

Sponsors & Collaborators

DermBiont, Inc.
Industrycollaborator
Eastman Dental Insitute and Hospital
Otherlead
The Whittington Hospital NHS Trust

Study Sites (1)

University College Hospital (UCH), UCL Eastman Dental Institute

London, United Kingdom

RECRUITING

Francesco D'Aiuto, DMD, PhD, MClinDentCONTACTf.daiuto@ucl.ac.uk

Francesco D'Aiuto, DMD, PhD, MClinDentPRINCIPAL INVESTIGATOR

Biospecimen

Retention: SAMPLES WITH DNA

Oral and nasal swab

MeSH Terms

Conditions

COVID-19Periodontitis

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract DiseasesPeriodontal DiseasesMouth Diseases

Central Study Contacts

Jeanie Suvan

CONTACT

+442034561108 j.suvan@ucl.ac.uk

Study Design

Study Type: observational
Observational Model: COHORT
Time Perspective: CROSS SECTIONAL
Sponsor Type: OTHER
Responsible Party: PRINCIPAL INVESTIGATOR
PI Title: Professor

Study Record Dates

First Submitted

December 11, 2020

First Posted

December 16, 2020

Study Start

December 13, 2020

Actual (reported)

Primary Completion

December 12, 2021

Estimated (date passed)

Oral Health, Microbial Burden and COVID-19

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

First Submitted

Study Start

First Posted

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (1)

Study Arms (3)

Controls tested PCR (-) for COVID-19

Tested PCR (+) for COVID-19, Mild - not admitted to the hospital

Tested PCR (+) for COVID-19, Severe - admitted to ICU (Intensive Care Unit)

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

Biospecimen

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Central Study Contacts

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

First Submitted

Study Start

First Posted

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (1)

Study Arms (3)

Controls tested PCR (-) for COVID-19

Tested PCR (+) for COVID-19, Mild - not admitted to the hospital

Tested PCR (+) for COVID-19, Severe - admitted to ICU (Intensive Care Unit)

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

Biospecimen

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Central Study Contacts

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations